Results for tag: "Dysautonomia Drug"

The Dysautonomia Drug market is a subset of the Central Nervous System Drugs market. It is composed of drugs used to treat dysautonomia, a disorder of the autonomic nervous system. Dysautonomia can cause a wide range of symptoms, including dizziness, fatigue, and difficulty regulating body temperature. Dysautonomia drugs are used to reduce symptoms and improve quality of life. These drugs can be divided into two categories: symptomatic treatments and disease-modifying treatments. Symptomatic treatments are used to reduce symptoms, while disease-modifying treatments are used to slow the progression of the disease. Some companies in the Dysautonomia Drug market include AbbVie, AstraZeneca, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more